Haoxi Health Technology Limited (HAO) Stock Analysis & Winston Score
Haoxi Health Technology Limited is a small Chinese company that provides digital advertising services, mainly focused on the health and wellness industry. It helps health-related businesses — such as pharmaceutical companies, medical device makers, and wellness brands — reach consumers through online platforms and social media channels in China. The company acts as a middleman, connecting advertisers with digital media inventory. Haoxi makes money by buying advertising space on digital platforms and reselling it to clients at a markup, which explains its very thin gross margin of around 5%. The company operates almost entirely in China and is quite small, with a market cap near zero. Its financial metrics, including a deeply negative operating margin and poor return on invested capital, signal that the business is currently spending more than it earns. The key risk is whether the company can scale its client base and improve margins in China's highly competitive digital advertising market, where larger players like Alibaba and Tencent dominate.
Winston Score: 22/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (1/30)
- Growth: Mixed (5/20)
- Cash Flow: Weak (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $0.15
Market Cap: $0M
Sector: Communication Services
Industry: Advertising Agencies
Exchange: NASDAQ Capital Market

